Phospholipid vesicle–bound lysozyme to enhance permeability in human intestinal cells

References

• Pauletti GM, Okumu FW, Borchardt RT. Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharm Res 1997;14:164–168.
   PubMed Web of Science ®Google Scholar
• Mcnally EJ, Park JY. (2002). Peptide and proteins - oral absorption. In: Swarbrick J, Boylan JC. (eds.) Encyclopedia of Pharmaceutical Technology. 2nd ed. New York: Marcel Dekker.
   Google Scholar
• Calcagno AM, Siahaan TJ. (2005). Physiological, biochemical, and chemical barriers to oral drug delivery. In: Wang B, Siahaan T, Soltero RA. (eds.) Drug delivery: Principles and Applications. New Jersey: John Wiley & Son, Inc.
   Google Scholar
• Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov 2003;2:289–295.
   PubMed Web of Science ®Google Scholar
• Anderson KE, Stevenson BR, Rogers JA. Folic acid-PEO-labeled liposomes to improve gastrointestinal absorption of encapsulated agents. J Control Release 1999;60:189–198.
   PubMed Web of Science ®Google Scholar
• Song KH, Chung SJ, Shim CK. Preparation and evaluation of proliposomes containing salmon calcitonin. J Control Release 2002;84:27–37.
   PubMed Web of Science ®Google Scholar
• Guo J, Ping Q, Jiang G, Huang L, Tong Y. Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm 2003;260:167–173.
   PubMed Web of Science ®Google Scholar
• Yamabe K, Kato Y, Onishi H, Machida Y. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. J Control Release 2003;89:429–436.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ferreira DC, Jorgensen L, van de Weert M. Probing insulin’s secondary structure after entrapment into alginate/chitosan nanoparticles. Eur J Pharm Biopharm 2007;65:10–17.
   PubMed Web of Science ®Google Scholar
• Ermak TH, Giannasca PJ. Microparticle targeting to M cells. Adv Drug Deliv Rev 1998;34:261–283.
   PubMed Web of Science ®Google Scholar
• Clark MA, Jepson MA, Hirst BH. Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev 2001;50:81–106.
   PubMed Web of Science ®Google Scholar
• Pukanud P, Peungvicha P, Sarisuta N. Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer’s patches. Drug Deliv 2009;16:289–294.
   PubMed Web of Science ®Google Scholar
• Jepson MA, Clark MA, Hirst BH. M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery. Adv Drug Deliv Rev 2004;56:511–525.
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping QN, Huang GH, Xu WF. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 2005;294:247–259.
   PubMed Web of Science ®Google Scholar
• Dorkoosh FA, Coos Verhoef J, Ambagts MH, Rafiee-Tehrani M, Borchard G, Junginger HE. Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin. Eur J Pharm Sci 2002;15:433–439.
   PubMed Web of Science ®Google Scholar
• Polnok A, Verhoef JC, Borchard G, Sarisuta N, Junginger HE. In vitro evaluation of intestinal absorption of desmopressin using drug-delivery systems based on superporous hydrogels. Int J Pharm 2004;269:303–310.
   PubMed Web of Science ®Google Scholar
• Sweetman S. (2009). Matindale: The complete drug reference. London: Pharmaceutical Press.
   Google Scholar
• Masci JR. Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme. AIDS 2000;14:2403–2404.
   PubMed Web of Science ®Google Scholar
• Yuzuriha T, Katayama K, Fujita T. Studies on biotransformation of lysozyme. I. Preparation of labeled lysozyme and its intestinal absorption. Chem Pharm Bull 1975;23:1309–1314.
   PubMedGoogle Scholar
• Seno S, Inoue S, Akita M, Setsu K, Tsugaru Y, Furuhata Y. Intestinal of lysozyme molecules and their destination, an immunohistochemical study on rat. Acta Histochem Cytochem 1998;31:329–334.
   Web of Science ®Google Scholar
• Hashida S, Ishikawa E, Nakamichi N, Sekino H. Concentration of egg white lysozyme in the serum of healthy subjects after oral administration. Clin Exp Pharmacol Physiol 2002;29:79–83.
   PubMed Web of Science ®Google Scholar
• Takano M, Koyama Y, Nishikawa H, Murakami T, Yumoto R. Segment-selective absorption of lysozyme in the intestine. Eur J Pharmacol 2004;502:149–155.
   PubMed Web of Science ®Google Scholar
• Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83:346–356.
   PubMed Web of Science ®Google Scholar
• Dong A, Huang P, Caughey WS. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 1990;29:3303–3308.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Li D. Interpreting multicomponent infrared spectra by derivative minimization. Appl Spectrosc 1991;45:1047–1049.
   Web of Science ®Google Scholar
• Gorga JC, Dong A, Manning MC, Woody RW, Caughey WS, Strominger JL. Comparison of the secondary structures of human class I and class II major histocompatibility complex antigens by Fourier transform infrared and circular dichroism spectroscopy. Proc Natl Acad Sci USA 1989;86:2321–2325.
   PubMed Web of Science ®Google Scholar
• Fabian H, Schultz C, Naumann D, Landt O, Hahn U, Saenger W. Secondary structure and temperature-induced unfolding and refolding of ribonuclease T1 in aqueous solution. A Fourier transform infrared spectroscopic study. J Mol Biol 1993;232:967–981.
   PubMed Web of Science ®Google Scholar
• Griebenow K, Klibanov AM. On protein denaturation in aqueous−organic mixtures but not in pure organic solvents. J Am Chem Soc 1996;118:11695–11700.
   Web of Science ®Google Scholar
• Lee CT, Mackley MR, Stonestreet P, Middelberg APJ. Protein refolding in an oscillatory flow reactor. Biotechnol Lett 2001;23:1899–1901.
   Google Scholar
• Liao YH, Brown MB, Martin GP. Turbidimetric and HPLC assays for the determination of formulated lysozyme activity. J Pharm Pharmacol 2001;53:549–554.
   PubMed Web of Science ®Google Scholar
• Poznansky MJ, Juliano RL. Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev 1984;36:277–336.
   PubMed Web of Science ®Google Scholar
• Rojanapanthu P, Sarisuta N, Chaturon K, Kraisintu K. Physicochemical properties of amphotericin B liposomes prepared by reverse-phase evaporation method. Drug Dev Ind Pharm 2003;29:31–37.
   PubMed Web of Science ®Google Scholar
• Witoonsaridsilp W, Panyarachun B, Sarisuta N, Müller-Goymann CC. Influence of microenvironment and liposomal formulation on secondary structure and bilayer interaction of lysozyme. Colloids Surf B Biointerfaces 2010;75:501–509.
   PubMed Web of Science ®Google Scholar
• Kuehner DE, Engmann J, Fergg F, Wernick M, Blanch HW, Prausnitz JM. Lysozyme net charge and ion binding in concentrated aqueous electrolyte solutions. The J Phys Chem B 1999;103:1368–1374.
   Web of Science ®Google Scholar
• Bergers JJ, Vingerhoeds MH, van Bloois L, Herron JN, Janssen LH, Fischer MJ et al. The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of water-soluble, globular proteins. Biochemistry 1993;32:4641–4649.
   PubMed Web of Science ®Google Scholar
• Zschörnig O, Paasche G, Thieme C, Korb N, Arnold K. Modulation of lysozyme charge influences interaction with phospholipid vesicles. Colloids Surf B Biointerfaces 2005;42:69–78.
   PubMedGoogle Scholar
• Costantino HR, Griebenow K, Mishra P, Langer R, Klibanov AM. Fourier-transform infrared spectroscopic investigation of protein stability in the lyophilized form. Biochim Biophys Acta 1995;1253:69–74.
   PubMedGoogle Scholar
• Malzert A, Boury F, Renard D, Robert P, Proust JE, Benoít JP. Influence of some formulation parameters on lysozyme adsorption and on its stability in solution. Int J Pharm 2002;242:405–409.
   PubMed Web of Science ®Google Scholar
• Van De Weert M, Van Dijkhuizen-Radersma R, Bezemer JM, Hennink WE, Crommelin DJA. Reversible aggregation of lysozyme in a biodegradable amphiphilic multiblock copolymer. Eur J Pharm Biopharm 2002;54:89–93.
   PubMed Web of Science ®Google Scholar
• Pagano RE, Weinstein JN. Interactions of liposomes with mammalian cells. Annu Rev Biophys Bioeng 1978;7:435–468.
   PubMedGoogle Scholar
• Florence AT. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res 1997;14:259–266.
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997;14:1568–1573.
   PubMed Web of Science ®Google Scholar
• Jani PU, Florence AT, Mccarthy DE. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int J Pharm 1992;84: 245–252.
   Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996;13:1838–1845.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 2005;303:160–170.
   PubMed Web of Science ®Google Scholar
• Boonyapiwat B, Sarisuta N, Kunastitchai S. Characterization and in vitro evaluation of intestinal absorption of liposomes encapsulating zanamivir. Curr Drug Deliv 2011;8:392–297.
   PubMedGoogle Scholar